Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study.
Published Apr 1, 2004 · H. Schuster, P. Barter, S. Stender
American heart journal
167
Citations
5
Influential Citations
Abstract
Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Key takeawaySwitching to rosuvastatin 10 mg significantly improves LDL-C goal achievement in high-risk patients requiring lipid-lowering therapy.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.